Listed

Definium Therapeutics, Inc.

DFTXNasdaqCIK 1813814HealthcareFiscal year ends Dec 31

Reports and events: 152 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Definium Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-04-2710:52 ET6-KReport of a foreign private issuerPeriod 2021-04-270001104659-21-055357
2021-04-2310:23 ET6-KReport of a foreign private issuerPeriod 2021-04-230001104659-21-054209

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.